Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

Cited In for PubMed (Select 15238592)

1.

Beneficial effects of soy supplementation on postmenopausal atherosclerosis are dependent on pretreatment stage of plaque progression.

Meléndez GC, Register TC, Appt SE, Clarkson TB, Franke AA, Kaplan JR.

Menopause. 2015 Mar;22(3):289-96. doi: 10.1097/GME.0000000000000307.

PMID:
25072952
2.

Nutraceuticals in cognitive impairment and Alzheimer's disease.

Mecocci P, Tinarelli C, Schulz RJ, Polidori MC.

Front Pharmacol. 2014 Jun 23;5:147. doi: 10.3389/fphar.2014.00147. eCollection 2014. Review.

3.

Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults.

Talaei M, Koh WP, van Dam RM, Yuan JM, Pan A.

J Nutr. 2014 Jun;144(6):921-8. doi: 10.3945/jn.114.190454. Epub 2014 Apr 3.

4.

Associations between urine excretion of isoflavonoids and cognition in postmenopausal women in the Women's Isoflavone Soy Health clinical trial.

St John JA, Henderson VW, Hodis HN, Kono N, McCleary CA, Franke AA, Mack WJ.

J Am Geriatr Soc. 2014 Apr;62(4):629-35. doi: 10.1111/jgs.12752. Epub 2014 Mar 11.

5.

The effects of dietary treatment with S-equol on learning and memory processes in middle-aged ovariectomized rats.

Neese SL, Pisani SL, Doerge DR, Helferich WG, Sepehr E, Chittiboyina AG, Rotte SC, Smillie TJ, Khan IA, Korol DL, Schantz SL.

Neurotoxicol Teratol. 2014 Jan-Feb;41:80-8. doi: 10.1016/j.ntt.2013.12.004. Epub 2013 Dec 22.

6.

Genistein exposure during the early postnatal period favors the development of obesity in female, but not male rats.

Strakovsky RS, Lezmi S, Flaws JA, Schantz SL, Pan YX, Helferich WG.

Toxicol Sci. 2014 Mar;138(1):161-74. doi: 10.1093/toxsci/kft331. Epub 2013 Dec 21.

7.

Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial.

Mangano KM, Hutchins-Wiese HL, Kenny AM, Walsh SJ, Abourizk RH, Bruno RS, Lipcius R, Fall P, Kleppinger A, Kenyon-Pesce L, Prestwood KM, Kerstetter JE.

Nutr Res. 2013 Dec;33(12):1026-33. doi: 10.1016/j.nutres.2013.08.009. Epub 2013 Sep 18.

8.

Isoflavone metabolism and bone-sparing effects of daidzein-metabolites.

Uehara M.

J Clin Biochem Nutr. 2013 May;52(3):193-201. doi: 10.3164/jcbn.13-2. Epub 2013 May 1.

9.

Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial.

Quaas AM, Kono N, Mack WJ, Hodis HN, Felix JC, Paulson RJ, Shoupe D.

Menopause. 2013 Aug;20(8):840-4. doi: 10.1097/GME.0b013e3182804353.

10.

Does phytoestrogen supplementation affect cognition differentially in males and females?

Sumien N, Chaudhari K, Sidhu A, Forster MJ.

Brain Res. 2013 Jun 13;1514:123-7. doi: 10.1016/j.brainres.2013.02.013. Epub 2013 Feb 13. Review.

11.

Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States.

Atkinson C, Newton KM, Yong M, Stanczyk FZ, Westerlind KC, Li L, Lampe JW.

Metabolism. 2012 Dec;61(12):1678-82. doi: 10.1016/j.metabol.2012.05.012. Epub 2012 Jul 21.

12.

Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases.

Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A.

Antioxid Redox Signal. 2013 May 10;18(14):1818-92. doi: 10.1089/ars.2012.4581. Epub 2012 Aug 27. Review.

13.

Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial.

Henderson VW, St John JA, Hodis HN, Kono N, McCleary CA, Franke AA, Mack WJ; WISH Research Group.

Neurology. 2012 Jun 5;78(23):1841-8. doi: 10.1212/WNL.0b013e318258f822.

14.

Dietary phytoestrogen intakes and cognitive function during the menopausal transition: results from the Study of Women's Health Across the Nation Phytoestrogen Study.

Greendale GA, Huang MH, Leung K, Crawford SL, Gold EB, Wight R, Waetjen E, Karlamangla AS.

Menopause. 2012 Aug;19(8):894-903. doi: 10.1097/gme.0b013e318242a654.

17.

The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study.

Tai TY, Tsai KS, Tu ST, Wu JS, Chang CI, Chen CL, Shaw NS, Peng HY, Wang SY, Wu CH.

Osteoporos Int. 2012 May;23(5):1571-80. doi: 10.1007/s00198-011-1750-7. Epub 2011 Sep 8.

18.

Effect of soybean supplementation on the memory of alprazolam-induced amnesic mice.

Bansal N, Parle M.

J Pharm Bioallied Sci. 2010 Apr;2(2):144-7. doi: 10.4103/0975-7406.67001.

19.

Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women.

Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Amato P, Young RL, Barnes S, Konzelmann KL, Fischer JG, Ellis KJ, Shypailo RJ, Fraley JK, Smith EO, Wong WW.

Am J Clin Nutr. 2011 Feb;93(2):356-67. doi: 10.3945/ajcn.110.008359. Epub 2010 Dec 22.

20.

A longitudinal study of the effect of genistein on bone in two different murine models of diminished estrogen-producing capacity.

Reinwald S, Mayer LP, Hoyer PB, Turner CH, Barnes S, Weaver CM.

J Osteoporos. 2010;2010. pii: 145170. doi: 10.4061/2010/145170. Epub 2009 Oct 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk